Podsumowanie

Powszechnie rejestrowane pogorszenie efektywności snu (skrócenie czasu trwania, pogorszenie jakości) negatywnie wpływa na stan zdrowia społeczeństwa.

Istnieje wiele dowodów wskazujących na ścisły związek zaburzeń snu z chorobami somatycznymi. Zaburzenia snu mogą predysponować do otyłości, niekorzystnie wpływać na gospodarkę węglowodanową powodując wzrost insulinooporności i wzrost szansy zachorowania na cukrzycę typu 2, a także liczne schorzenia w zakresie układu krążenia. Fakt ten jest szczególnie ważny w społeczeństwach, w których choroby układu krążenia stanowią pierwszą przyczynę przedwczesnych zgonów.

Wydaje się zasadne, aby konsekwentnie podkreślać konieczność zachowania elementarnej higieny snu i leczenia jego zaburzeń w zaleceniach dotyczących prozdrowotnych zmian stylu życia pacjentów.

Abstract
Over the past sixty years the average sleep duration decreased substantially in westernized societies. Several factors underlie this phenomenon among which socio-economic pressure, poor sleep hygiene, and sleep disorders appear to be the most important ones. Evidently, sleep disorders such as insomnia, obstructive sleep apnea, periodic legs movements during sleep/restless legs syndrome, or depression-related sleep disorders are much more common in 21st century societies. Regardless the primary cause, poor sleep quality substantially affect psycho-, and somatic health. There is growing evidence indicating that insufficient sleep may be implicated in abnormal glucose metabolism, body weight control as well as cardiovascular morbidity and mortality.

Keywords: sleep duration, obstructive sleep apnea, obesity, glucose metabolism, insulin resistance, cardiovascular disease.

Zdjęcia: archiwum prywatne (3)

Piśmiennictwo

1. Bixler E. Sleep and society: An epidemiological perspective. Sleep Medicine 2009;10:S3-S6

2. Donga E, van Dijk M, vanDijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 2010;95:2963-68

3. Rutters F, Besson H, Walker M, et al. The Association Between Sleep Duration, Insulin Sensitivity, and β-Cell Function: The EGIR-RISC Study. J Clin Endocrinol Metab 2016;29:jc20161045

4. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-14

5. Heinzer R, Vat S, Marques-Vidal P, et. al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015;3(4):310-8

6. Pamidi S, Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link? Front Neurol. 2012 Aug 13;3:126

7. Punjabi NM, Shahar E, Redline S, et al. Sleep Heart Health Study Investigators. Sleep- disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160(6):521-30

8. Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172(12):1590-95

9. Singh P, Somers VK. Obstructive sleep apnea, diabetes, and obesity: Partners in crime? Sleep medicine; w druku

10. Aronsohn RS, Whitmore H, Van Cauter E, et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010;181(5):507-13

11. Briançon-Marjollet A, Weiszenstein M, Henri M, et al. The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr 2015;7:25

12. Hui P, Zhao L, Xie Y, et al. Nocturnal Hypoxemia Causes Hyperglycemia in Patients With Obstructive Sleep Apnea and Type 2 Diabetes Mellitus. Am J Med Sci 2016 Feb;351(2):160-8

13. Polak J, Shimoda LA, Drager LF, et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep 2013;36(10):1430-90;1490A-1490B

14. Liyori N, Alonso LC, Li J, et al.Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007;175(8):851-7

15. Carreras A, Kayali F, Zhang J, et al. Metabolic effects of intermittent hypoxia in mice: steady versus high-frequency applied hypoxia daily during the rest period. Am J Physiol Regul Integr Comp Physiol 2012;303:R700-9

16. Ota H, Tamaki S, Itaya-Hironaka A, et al. Attenuation of glucose-induced insulin secretion by intermittent hypoxia via down-regulation of CD38. Life Sci. 2012;90:206-11

17. Chapman CD, Benedict C, Brooks SJ, Schioth HB. Lifestyle determinants of the drive to eat: a meta-analysis. Am J Clin Nutr 2012;96:492-7

18. Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity 2008;16(3):643-53

19. Chaput JP, McNeil J, Després JP, et al. Short sleep duration as a risk factor for development of the metabolic syndrome in adults. Prev Med 2013 Dec;57(6):872-7

20. Pływaczewski R, Brzecka A, Bielecki P, et al. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania i leczenia zaburzeń oddechu w czasie snu (ZOCS) u dorosłych. Pneumonologia i Alergologia Polska 2013;3:221-58

21. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000 Dec 20;284(23):3015-21

22. Laaban JP, Daenen S, Leger D, et al. Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 2009;35:372-77

23. Poulain L, Thomas A, Rieusset J, et al. Visceral white fat remodelling contributes to intermittent hypoxia-induced atherogenesis. Eur Respir J 2014;43:513-22

24. Aron-Wisnewsky J, Minville C, Tordjman J, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 2012;56:225-33

25. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension HYPERLINK „http://www.ncbi.nlm.nih.gov/pubmed/16585410”. 2006 May;47(5):833-39

26. Cappuccio FP, Cooper D, D’Elia L, et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. European Heart Journal (2011) 32,1484-92

27. Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep- disordered breathing and hypertension. N Engl J Med 2000:342:1378-84

28. Narkiewicz K, Somers VK, Symapthetic nerve activity in obstrucitive sleep apnoea. Acat Physiol Scand 2003;177:385-90

29. Feng Y, Zhang Z, Dong ZZ. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis. NPJ Prim Care Respir Med 2015;25:15005

30. Purnell JO, Selzer F, Wahed AS, et al. Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study. Diabetes Care 2016 Jul;39(7):1101-7

Do góry